Source: Medpage Today
“Treating herpes simplex type 2 (HSV-2) slows the progression of HIV in people infected with both, researchers have found.
In a large randomized trial in Africa, giving the herpes drug acyclovir (Zovirax) reduced the risk of HIV progression by 16% among people not yet eligible for antiretroviral therapy, according to Jairam Lingappa, MD, of the University of Washington in Seattle, and colleagues.
The finding comes after earlier research — some of it from the same trial — showed that treating herpes simplex does not reduce the risk of transmitting HIV, Lingappa and colleagues said online in The Lancet.”
Click here to read more.
Advertisement
